Synaptics, Inc. (SYNA) Tops Q2 EPS by 8c; Guides Q4 Revs Above the Street

Synaptics, Inc. (NASDAQ: SYNA) reported Q2 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter came in at $143 million versus the consensus estimate of $137.71 million.

Synaptics, Inc. sees Q4 revenue of $140-148 million, versus the consensus of $133.74 million.

For earnings history and earnings-related data on Synaptics, Inc. (SYNA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c